# Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma

> **NCT02370849** · PHASE2 · COMPLETED · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 2 (actual)

## Conditions studied

- Stomach Neoplasms

## Interventions

- **DRUG:** nimotuzumab
- **DRUG:** cisplatin
- **DRUG:** S-1

## Key facts

- **NCT ID:** NCT02370849
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2012-02
- **Final completion:** 2015-02
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2015-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02370849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02370849, "Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02370849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*